Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of "Buy" from Analysts

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has received an average rating of "Buy" from the fourteen brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $27.38.

Several research analysts recently weighed in on PRVA shares. Needham & Company LLC reissued a "buy" rating and issued a $30.00 target price on shares of Privia Health Group in a research note on Thursday, April 10th. Canaccord Genuity Group raised their target price on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, February 28th. Truist Financial lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. JMP Securities reaffirmed a "market outperform" rating and set a $29.00 price target on shares of Privia Health Group in a report on Monday, April 28th. Finally, Piper Sandler increased their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th.

Privia Health Group Stock Performance

PRVA opened at $25.06 on Tuesday. The business's fifty day moving average is $23.37 and its two-hundred day moving average is $22.39. The company has a market cap of $3.04 billion, a price-to-earnings ratio of 250.63, a PEG ratio of 3.47 and a beta of 0.87. Privia Health Group has a one year low of $15.92 and a one year high of $26.09.

Insider Activity

In other news, CEO Parth Mehrotra sold 15,100 shares of the firm's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares of the company's stock, valued at approximately $10,598,375.73. This trade represents a 3.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Mountcastle sold 3,445 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $80,371.85. Following the completion of the sale, the chief financial officer now directly owns 176,231 shares of the company's stock, valued at approximately $4,111,469.23. This trade represents a 1.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,484 shares of company stock valued at $799,163 over the last 90 days. 10.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Privia Health Group

A number of hedge funds have recently modified their holdings of PRVA. Barclays PLC lifted its position in Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock worth $4,079,000 after buying an additional 158,188 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock worth $3,430,000 after acquiring an additional 14,641 shares during the period. Park Avenue Securities LLC raised its position in shares of Privia Health Group by 3.8% in the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company's stock valued at $287,000 after buying an additional 532 shares in the last quarter. Financial Management Professionals Inc. acquired a new stake in Privia Health Group in the fourth quarter valued at about $51,000. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock worth $98,000 after buying an additional 3,249 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.